Protara Therapeutics Inc.

(TARA) Trade

By |

Profile

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Contact Information

Website: www.protaratx.com
Email: inquiries@artaratx.com
Main Phone: +1 646 844-0337
Address: 1 Little West 12th Street
State: NY
City / Town: New York
Country: US
Postal Code: 10014

Issuer Information

Exchange: NSD
CEO: Jesse Shefferman
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Contact Information

Website: www.protaratx.com
Email: inquiries@artaratx.com
Main Phone: +1 646 844-0337
Address: 1 Little West 12th Street
State: NY
City / Town: New York
Country: US
Postal Code: 10014

Issuer Information

Exchange: NSD
CEO: Jesse Shefferman
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 17.94 $ -0.72 (-3.86%)
Last Price 17.94 Change $ -0.72 Change % -3.86 Tick N/A
Bid 17.18 Bid Size 1.00 Ask 18.50 Ask Size 7.00
Open 18.51 High 18.77 Low 16.90 Prev Close 18.66
Last Trade Volume 88,935 52 Wk Hi 67.08 52 Wk Low 8.82
Market Cap 105.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,858,386.00 EPS (TTM) -7.82 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 7
Number of Buys 2 4
Number of Sells 0 3
Net Activity 830233 822899
Last 10 Buys Shares
Steven Keith Burke 1,000
Flynn E James 1,000
George Eldridge 1,000
George Eldridge 1,000
George Eldridge 1,000
George Eldridge 1,000
George Eldridge 1,000
Brendan O'Leary 1,000
Flynn E James 1,000
Flynn E James 1,000
Last 10 Sell Shares
Flynn E James 1,000
Timothy P. Noyes 1,000
Timothy P. Noyes 1,000
Timothy P. Noyes 1,000
Timothy P. Noyes 1,000
Timothy P. Noyes 1,000
Daniel Philip Gottlieb 1,000
John G. Freund 1,000
John G. Freund 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/11/19 02/11/19 02/11/19 02/11/19
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.33 2.33 2.33 2.33